TrialTrials2025

Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity.

Arash Mansoori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.